Literature DB >> 10902778

Clinical review 114: hot topic. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases.

L C Hofbauer1, A E Heufelder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10902778     DOI： 10.1210/jcem.85.7.6702

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  37 in total

Review 1.  Theories concerning the pathogenesis of the acute charcot foot suggest future therapy.

Authors:  William J Jeffcoate
Journal:  Curr Diab Rep       Date:  2005-12       Impact factor: 4.810

2.  Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing.

Authors:  Alessandra Colombini; Giovanni Lombardi; Emanuela Galliera; Giada Dogliotti; Pietro Randelli; Alexander Meerssemann; Giuseppe Mineo; Paolo Cabitza; Massimiliano Marco Corsi
Journal:  Int Orthop       Date:  2010-07-11       Impact factor: 3.075

Review 3.  Minimizing bone abnormalities in children with renal failure.

Authors:  Helena Ziólkowska
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

4.  Targeted ovarian cancer treatment: the TRAILs of resistance.

Authors:  Nadzeya Goncharenko Khaider; Denis Lane; Isabelle Matte; Claudine Rancourt; Alain Piché
Journal:  Am J Cancer Res       Date:  2011-11-21       Impact factor: 6.166

5.  Hepatic osteodystrophy: does the osteoprotegerin/receptor activator of nuclear factor-kB ligand system play a role?

Authors:  A Gaudio; A Lasco; N Morabito; M Atteritano; C Vergara; A Catalano; W Fries; A Trifiletti; N Frisina
Journal:  J Endocrinol Invest       Date:  2005-09       Impact factor: 4.256

6.  High-dose vitamin D: helpful or harmful?

Authors:  Karen E Hansen
Journal:  Curr Rheumatol Rep       Date:  2011-06       Impact factor: 4.592

7.  Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system in patients with beta-thalassemia major.

Authors:  Nicholas G Angelopoulos; Anastasia Goula; Eugenia Katounda; Grigorios Rombopoulos; Victoria Kaltzidou; Dimitrios Kaltsas; Sophia Malaktari; Vassilis Athanasiou; George Tolis
Journal:  J Bone Miner Metab       Date:  2007-01-01       Impact factor: 2.626

Review 8.  Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link?

Authors:  W Jeffcoate
Journal:  Diabetologia       Date:  2004-08-21       Impact factor: 10.122

9.  Cyclic variations of bone resorption mediators and markers in the different phases of the menstrual cycle.

Authors:  Bruno Mozzanega; Salvatore Gizzo; Daniela Bernardi; Luigi Salmaso; Tito Silvio Patrelli; Roberto Mioni; Livio Finos; Giovanni Battista Nardelli
Journal:  J Bone Miner Metab       Date:  2013-03-12       Impact factor: 2.626

10.  Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot.

Authors:  Luigi Uccioli; Anna Sinistro; Cristiana Almerighi; Chiara Ciaprini; Antonella Cavazza; Laura Giurato; Valeria Ruotolo; Francesca Spasaro; Erika Vainieri; Giovanni Rocchi; Alberto Bergamini
Journal:  Diabetes Care       Date:  2009-10-30       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.